
Scinai Immunotherapeutics Secures $2.61 Million to Expand CDMO Platform and Advance Pipeline
Scinai Immunotherapeutics announced a $2.61 million private placement and warrant inducement to fund its CDMO expansion and immunotherapy pipeline development.
Read full story






















